CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View
Cardinal Health's first-quarter fiscal 2025 results benefit from solid Pharmaceutical and Specialty Solutions growth. However, OptumRx contract expiry hurts sales.
https://www.zacks.com/stock/news/2362758/cah-stocks-gains-on-q1-earnings-sales-beat-and-raised-25-eps-view